Ilsung Is Co., Ltd. (KRX: 003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,800
+190 (1.22%)
Nov 18, 2024, 3:30 PM KST
-22.36%
Market Cap 110.11B
Revenue (ttm) 73.22B
Net Income (ttm) -20.18B
Shares Out 6.97M
EPS (ttm) -2,964.44
PE Ratio n/a
Forward PE n/a
Dividend 1,500.00 (9.61%)
Ex-Dividend Date n/a
Volume 6,516
Open 15,550
Previous Close 15,610
Day's Range 15,550 - 16,200
52-Week Range 15,200 - 29,000
Beta -0.24
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.